Hypoglycemia and Autonomic Nervous System Function-B
Status:
Active, not recruiting
Trial end date:
2022-01-04
Target enrollment:
Participant gender:
Summary
This study tests the hypothesis that, compared to prior normal blood sugar, prior low blood
sugar impairs cardiovascular autonomic function. The proposed studies will also test the
hypothesis that the effects of prior low blood sugar on cardiovascular autonomic function are
blocked by administration of a mineralocorticoid receptor antagonist.
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital
Collaborators:
Beth Israel Deaconess Medical Center National Heart, Lung, and Blood Institute (NHLBI)